Today's most holistic solution for optimizing the accountability and reconciliation process

You have been chosen to receive this valuable information.

Current drug accountability and reconciliation processes can prolong clinical trial closeout by up to two years. It's time to get your clinical trial sites off of paper, and turn your chain of custody into a work of ART™.

ART™ can:

Speed study close out

Increase patient safety

Support compliance with GCP

Learn more at almacgroup.com/ART

Almac Group 25 Fretz Road Souderton, PA 18964 United States of America

You received this email because you are subscribed to Marketing Information from Almac Group.

Update your email preferences to choose the types of emails you receive.

Unsubscribe from all future emails

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Applied Clinical Trails, a UBM publication. You are on the mailing list as %%emailaddress%%.